REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 433 filers reported holding REPLIGEN CORP in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,021,169 | -0.6% | 29,824 | 0.0% | 0.24% | -10.0% |
| Q4 2022 | $5,049,501 | -9.5% | 29,824 | 0.0% | 0.26% | -13.0% |
| Q3 2022 | $5,580,000 | +50.1% | 29,824 | +30.3% | 0.30% | +64.8% |
| Q2 2022 | $3,718,000 | -13.7% | 22,893 | 0.0% | 0.18% | +21.3% |
| Q1 2022 | $4,306,000 | -29.0% | 22,893 | 0.0% | 0.15% | -15.3% |
| Q4 2021 | $6,063,000 | -8.4% | 22,893 | 0.0% | 0.18% | -12.8% |
| Q3 2021 | $6,616,000 | +44.8% | 22,893 | 0.0% | 0.20% | +79.6% |
| Q2 2021 | $4,570,000 | +2.7% | 22,893 | 0.0% | 0.11% | -2.6% |
| Q1 2021 | $4,451,000 | +1.5% | 22,893 | 0.0% | 0.12% | +1.8% |
| Q4 2020 | $4,387,000 | +29.9% | 22,893 | 0.0% | 0.11% | +21.3% |
| Q3 2020 | $3,378,000 | +19.4% | 22,893 | 0.0% | 0.09% | +5.6% |
| Q2 2020 | $2,830,000 | – | 22,893 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |